TNFRSF10D and prostate cancer: High DcR2 expression levels in patients with prostate cancer (PCa) indicate a poorer prognosis, with this marker strongly correlated with high Gleason Scores, Prostate Specific Antigen (PSA) recurrence and decreased survival in PCa patients [36].